Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Progesterone's seizure-reducing effects are mainly due to allopregnanolone, not progesterone receptors.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Suppressing ODC activity reduces tumor growth in hair follicles.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

These medications for BPH have known risks and may have new side effects.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

Stronger regulation and collaboration are needed to ensure online pharmacies are safe and legitimate.

Etifoxine, an anxiety drug, can lessen brain inflammation and cognitive issues in mice, partly by increasing production of protective brain steroids.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Norepinephrine is better than dopamine for treating low blood pressure from minoxidil overdose.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

New male contraceptive pills show promise in reducing sperm production with mild side effects.

Diethylpropion helps with weight loss but can interact dangerously with antidepressants and rarely causes hair loss.

Environmental factors can greatly reduce drug levels in hair.

Potential new drugs for treating PCOS were identified.

Removing certain brain receptors in mice worsens seizure severity and response to treatment during hormone withdrawal.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

GD-23 reduces anxiety by relying on neurosteroid production.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.